Aerie Pharma (AERI) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts AERI Hot Sheet
Join SI Premium – FREE
Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($0.67), in-line with the analyst estimate of ($0.67).
For earnings history and earnings-related data on Aerie Pharma (AERI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
